Defilade Capital Management »

Solventum Corp shares owned by Defilade Capital Management

Quarter-by-quarter ownership of Solventum Corp (SOLV) shares owned by Defilade Capital Management from 13F filings

Historical chart of Defilade Capital Management investment in Solventum Corp

Tip: Access up to 7 years of quarterly data

All positions including Solventum Corp held by Defilade Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Solventum Corp by Defilade Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $24M 317k 77.15

More positions owned by Defilade Capital Management

Eli Lilly & Co. (LLY)
Pfizer (PFE)
Veeva Sys Cl A Com (VEEV)
BioMarin Pharmaceutical (BMRN)
Ptc Therapeutics I (PTCT)
Baxter International (BAX)
Insmed Com Par $.01 (INSM)
Zimmer Holdings (ZBH)
Insulet Corporation (PODD)
Thermo Fisher Scientific (TMO)
Abbott Laboratories (ABT)
Ascendis Pharma A/s Ord Shs (ASND)
Solventum Corp Com Shs (SOLV)
Medtronic SHS (MDT)
Elanco Animal Health (ELAN)

View all positions for Defilade Capital Management

Top funds holding Solventum Corp

Independent Franchise Partners
BlackRock
Vanguard Capital Management
Trian Fund Management
State Street Corporation
Vanguard Portfolio Management
Davis Selected Advisers
Geode Capital Management
Robeco Investment Management
Invesco
FMR
State Farm Mutual Automobile Insurance Company
Diamond Hill Capital Management
Dimensional Fund Advisors
Morgan Stanley

View all funds holding Solventum Corp